Training in Extracellular Vesicles: for benefit in Health and Disease

Project Information

TRAIN-EV

Grant agreement ID: 722148

DOI

10.3030/722148

Project closed

EC signature date 30 August 2017

Start date 1 October 2017

End date 31 March 2022

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 3 724 252,54

EU contribution

€ 3 724 252,20

Coordinated by

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Ireland

Periodic Reporting for period 2 - TRAIN-EV (Training in Extracellular Vesicles: for benefit in Health and Disease)

Reporting period: 2019-10-01 to 2022-03-31

Summary of the context and overall objectives of the project

In the Reporting Period of TRAIN-EV (01/10/2019-31/03/2022) all ESRs either completed their projects or progressed onto another funding stream identified by their supervisors in order for them to complete and submit their PhDs. The 17 remaining Deliverables were submitted, and the 6 remaining Milestones achieved. Dissemination, by the ESRs was in the form of 29 oral presentations at conferences, 26 posters presentation at meetings, and 28 peer-reviewed publications. TRAIN-EV research was further highlighted and the H2020 funding gratefully received was acknowledged in 32 talks/keynotes, 10 peer-reviewed publications, and 9 exhibitions by Coordinators, Beneficiaries or Partner Organisations. We are very grateful to our Project Officer, Domna Paschalidou, for her advice, guidance, and support during this time, which was made challenging due to covid-19. However, our overall lasting impression of TRAIN-EV has been a time of great scientific collaboration and progress.

Work performed from the beginning of the project to the end of the period covered by the report and main results achieved so far

The work performed during the first reporting period within TRAIN-EV is in line with the Annex 1 to the Grant Agreement. Specifically, the TRAIN-EV training network has overall progressed as it was planned for this first reporting period, and is fully established and on the right track to conduct the training activities. TRAIN-EV ESRs are making substantial progress in their research, training and networking.
Overall, we are successful in progressing along the proposed project(s) timeline while keeping the pace with evolving knowledge and technology evolution in EV field and considering the emerging or persistent clinical needs.
The main results achieved so far are illustrated in the 3 published articles, 11 conference oral presentations and 6 posters.

Progress beyond the state of the art and expected potential impact (including the socio-economic impact and the wider societal implications of the project so far)

TRAIN-EV projects contribute individually and collectively to the advancement of EVs’ isolation and characterisation techniques, which enables further understanding of molecular mechanisms for EVs. A final aim of these projects is to evaluate and optimise EVs’ use in diagnosis and treatment, with significant impact on society health status.

train-ev-consortium.jpg